Molly Perkins

1.7k total citations · 1 hit paper
17 papers, 1.3k citations indexed

About

Molly Perkins is a scholar working on Virology, Immunology and Molecular Biology. According to data from OpenAlex, Molly Perkins has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Virology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Molly Perkins's work include HIV Research and Treatment (8 papers), Immune Cell Function and Interaction (5 papers) and HIV/AIDS Research and Interventions (3 papers). Molly Perkins is often cited by papers focused on HIV Research and Treatment (8 papers), Immune Cell Function and Interaction (5 papers) and HIV/AIDS Research and Interventions (3 papers). Molly Perkins collaborates with scholars based in United States, United Kingdom and France. Molly Perkins's co-authors include Daniel C. Douek, Tom Wilkinson, Tao Dong, Ben Nicholas, Cecilia Chui, Rob Lambkin‐Williams, Ang Huang, John Oxford, Karl J. Staples and Xiao-Ning Xu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Blood.

In The Last Decade

Molly Perkins

16 papers receiving 1.3k citations

Hit Papers

Preexisting influenza-specific CD4+ T cells correlate wit... 2012 2026 2016 2021 2012 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Molly Perkins United States 10 635 582 384 285 277 17 1.3k
Liyen Loh Australia 27 789 1.2× 1.6k 2.8× 352 0.9× 364 1.3× 399 1.4× 52 2.3k
Lesia Dropulic United States 15 480 0.8× 338 0.6× 244 0.6× 113 0.4× 146 0.5× 24 1.2k
Claudia D’Agostino Italy 19 307 0.5× 248 0.4× 321 0.8× 268 0.9× 105 0.4× 36 1.0k
Eli Boritz United States 15 241 0.4× 527 0.9× 350 0.9× 730 2.6× 129 0.5× 30 991
Erika Benko Canada 21 296 0.5× 831 1.4× 584 1.5× 931 3.3× 217 0.8× 41 1.6k
P Schipper Netherlands 20 797 1.3× 159 0.3× 1.7k 4.3× 1.3k 4.6× 299 1.1× 34 2.4k
Ivan Stratov Australia 27 557 0.9× 1.4k 2.4× 600 1.6× 1.2k 4.3× 310 1.1× 43 2.2k
Teena Mohan India 17 361 0.6× 431 0.7× 227 0.6× 69 0.2× 321 1.2× 26 954
François Roman Belgium 17 680 1.1× 367 0.6× 385 1.0× 185 0.6× 150 0.5× 44 1.0k
Yanhua Tang China 18 282 0.4× 1.0k 1.8× 462 1.2× 1.2k 4.3× 315 1.1× 41 1.6k

Countries citing papers authored by Molly Perkins

Since Specialization
Citations

This map shows the geographic impact of Molly Perkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly Perkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly Perkins more than expected).

Fields of papers citing papers by Molly Perkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly Perkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly Perkins. The network helps show where Molly Perkins may publish in the future.

Co-authorship network of co-authors of Molly Perkins

This figure shows the co-authorship network connecting the top 25 collaborators of Molly Perkins. A scholar is included among the top collaborators of Molly Perkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly Perkins. Molly Perkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hoff, Fieke W., Molly Perkins, Eugene O. Major, et al.. (2023). Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report. Therapeutic Advances in Hematology. 14. 1564119481–1564119481. 2 indexed citations
2.
Mudd, Joseph C., Stephen Y. Lai, Andrew R. Rahmberg, et al.. (2020). Epigenetic silencing of CD4 expression in nonpathogenic SIV infection in African green monkeys. JCI Insight. 5(18). 9 indexed citations
3.
Mudd, Joseph C., Molly Perkins, Sarah R. DiNapoli, Vanessa M. Hirsch, & Jason M. Brenchley. (2016). Interleukin-2 Therapy Induces CD4 Downregulation, Which Decreases Circulating CD4 T Cell Counts, in African Green Monkeys. Journal of Virology. 90(12). 5750–5758. 5 indexed citations
4.
Grande, Shannon, Molly Perkins, Holly M. Horton, et al.. (2016). Abstract 2296: Inhibition of the PI3K/Akt pathway during CAR T cell production results in enhanced efficacy across multiple in vivo tumor models. Cancer Research. 76(14_Supplement). 2296–2296. 1 indexed citations
5.
Ortiz, Ana M., Zachary Klase, Sarah R. DiNapoli, et al.. (2015). IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques. Mucosal Immunology. 9(2). 458–467. 72 indexed citations
6.
Perkins, Molly, István Bartha, J. Katherina Timmer, et al.. (2015). The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals. The Journal of Infectious Diseases. 212(4). 578–584. 18 indexed citations
7.
Perkins, Molly, Shannon Grande, Holly M. Horton, et al.. (2015). Manufacturing an Enhanced CAR T Cell Product By Inhibition of the PI3K/Akt Pathway During T Cell Expansion Results in Improved In Vivo Efficacy of Anti-BCMA CAR T Cells. Blood. 126(23). 1893–1893. 23 indexed citations
8.
Calantone, Nina, Fan Wu, Zachary Klase, et al.. (2014). Tissue Myeloid Cells in SIV-Infected Primates Acquire Viral DNA through Phagocytosis of Infected T Cells. Immunity. 41(3). 493–502. 86 indexed citations
9.
Klase, Zachary, Venkat S. R. K. Yedavalli, Laurent Houzet, et al.. (2014). Activation of HIV-1 from Latent Infection via Synergy of RUNX1 Inhibitor Ro5-3335 and SAHA. PLoS Pathogens. 10(3). e1003997–e1003997. 55 indexed citations
10.
Frohman, Elliot M., Maria Chiara Monaco, Gina Remington, et al.. (2014). JC Virus in CD34+and CD19+Cells in Patients With Multiple Sclerosis Treated With Natalizumab. JAMA Neurology. 71(5). 596–596. 60 indexed citations
11.
Perkins, Molly, Nina Calantone, Sonya Whitted, et al.. (2014). Homeostatic Cytokines Induce CD4 Downregulation in African Green Monkeys Independently of Antigen Exposure To Generate Simian Immunodeficiency Virus-Resistant CD8αα T Cells. Journal of Virology. 88(18). 10714–10724. 9 indexed citations
12.
Klatt, Nichole R., Lauren Canary, Xiaoyong Sun, et al.. (2013). Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. Journal of Clinical Investigation. 123(2). 903–7. 143 indexed citations
13.
Perkins, Molly, Caroline F. Ryschkewitsch, Maria Chiara Monaco, et al.. (2012). Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. PLoS Pathogens. 8(11). e1003014–e1003014. 36 indexed citations
14.
Wilkinson, Tom, Cecilia Chui, Ang Huang, et al.. (2012). Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nature Medicine. 18(2). 274–280. 766 indexed citations breakdown →
15.
Bumb, Ambika, Celeste A.S. Regino, Molly Perkins, et al.. (2010). Preparation and characterization of a magnetic and optical dual-modality molecular probe. Nanotechnology. 21(17). 175704–175704. 24 indexed citations
16.
Bumb, Ambika, Celeste A.S. Regino, Molly Perkins, et al.. (2010). Preparation and characterization of a magnetic and optical dual-modality molecular probe. Nanotechnology. 21(20). 209803–209803.
17.
Hetzel, M, et al.. (1985). Is sodium cromoglycate effective in nocturnal asthma?. Thorax. 40(10). 793–794. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026